Sánchez-Álvarez Emilio, Rodríguez-García Minerva, Locatelli Francesco, Zoccali Carmine, Martín-Malo Alejandro, Floege Jürgen, Ketteler Markus, London Gerard, Górriz José L, Rutkowski Boleslaw, Ferreira Anibal, Pavlovic Drasko, Cannata-Andía Jorge B, Fernández-Martín José L
Department of Nephrology, Hospital Universitario de Cabueñes, REDinREN del ISCIII, Gijón, Spain.
Department of Nephrology, REDinREN del ISCIII, Hospital Universitario Central de Asturias, Oviedo, Spain.
Clin Kidney J. 2020 Dec 26;14(8):1915-1923. doi: 10.1093/ckj/sfaa233. eCollection 2021 Aug.
Besides advances in haemodialysis (HD), mortality rates are still high. The effect of the different types of HD membranes on survival is still a controversial issue. The aim of this COSMOS (Current management Of Secondary hyperparathyroidism: a Multicentre Observational Study) analysis was to survey, in HD patients, the relationship between the use of conventional low- or high-flux membranes and all-cause and cardiovascular mortality.
COSMOS is a multicentre, open-cohort, 3-year prospective study, designed to evaluate mineral and bone disorders in the European HD population. The present analysis included 5138 HD patients from 20 European countries, 3502 randomly selected at baseline (68.2%), plus 1636 new patients with <1 year on HD (31.8%) recruited to replace patients who died, were transplanted, switched to peritoneal dialysis or lost to follow-up by other reasons. Cox-regression analysis with time-dependent variables, propensity score matching and the use of an instrumental variable (facility-level analysis) were used.
After adjustments using three different multivariate models, patients treated with high-flux membranes showed a lower all-cause and cardiovascular mortality risks {hazard ratio (HR) = 0.76 [95% confidence interval (CI) 0.61-0.96] and HR = 0.61 (95% CI 0.42-0.87), respectively}, that remained significant after matching by propensity score for all-cause mortality (HR = 0.69, 95% CI 0.52-0.93). However, a facility-level analysis showed no association between the case-mix-adjusted facility percentage of patients dialysed with high-flux membranes and all-cause and cardiovascular mortality.
High-flux dialysis was associated with a lower relative risk of all-cause and cardiovascular mortality. However, dialysis facilities using these dialysis membranes to a greater extent did not show better survival.
除血液透析(HD)技术取得进展外,死亡率仍然很高。不同类型的HD膜对生存率的影响仍是一个有争议的问题。本COSMOS(继发性甲状旁腺功能亢进的当前管理:一项多中心观察性研究)分析的目的是调查HD患者中使用传统低通量或高通量膜与全因死亡率和心血管死亡率之间的关系。
COSMOS是一项多中心、开放队列、为期3年的前瞻性研究,旨在评估欧洲HD人群中的矿物质和骨疾病。本分析纳入了来自20个欧洲国家的5138例HD患者,其中3502例在基线时随机选取(68.2%),另外1636例HD治疗时间<1年的新患者(31.8%),这些新患者是为了替代死亡、接受移植、转为腹膜透析或因其他原因失访的患者而招募的。使用了具有时间依赖性变量的Cox回归分析、倾向评分匹配以及工具变量的使用(机构水平分析)。
在使用三种不同的多变量模型进行调整后,使用高通量膜治疗的患者全因死亡率和心血管死亡率风险较低{风险比(HR)分别为0.76[95%置信区间(CI)0.61 - 0.96]和HR = 0.61(95%CI 0.42 - 0.87)},在按倾向评分匹配全因死亡率后仍具有显著性(HR = 0.69,95%CI 0.52 - 0.93)。然而,机构水平分析显示,经病例组合调整的使用高通量膜透析的患者机构百分比与全因死亡率和心血管死亡率之间无关联。
高通量透析与较低的全因死亡率和心血管死亡率相对风险相关。然而,更大程度使用这些透析膜的透析机构并未显示出更好的生存率。